FDA Obesity Drug: Update
July 24, 2010
An FDA advisory panel chose not to recommend approval of a new weight-loss drug call Qnexa.
Topics:
Hospitality Recreation, Health Medical Pharma, Social Issues, Health, Food and Drug Administration, Medicine, FDA, Yossi Gross, Orlistat, Anti-obesity medication, Biology, Obesity
